Savino J A, Cerabona T, Agarwal N, Byrne D
Department of Surgery, New York Medical College, Valhalla 10595.
Ann Surg. 1988 Oct;208(4):504-11. doi: 10.1097/00000658-198810000-00012.
Intra-abdominal pressure (IAP), measured via a transurethral catheter, hemodynamic, and renal functions were evaluated in 25 cirrhotic patients admitted to ICU with variceal bleeding, tense ascites, and peripheral edema. In patients with an IAP greater than 25 cm H2O, a paracentesis was performed to decrease the IAP by 10 cm H2O. After paracentesis, a decrease in the IAP from 33.47 to 19.06 cm H2O (p less than 0.001) resulted in a decrease in total peripheral resistance (TPR) (p less than 0.01) and a significant increase in cardiac index (CI) (p less than 0.001), stroke index (p less than 0.001), left ventricular stroke work (LVSW) (p less than 0.01), and right ventricular stroke work (p less than 0.01). The therapeutic effects of paracentesis on renal function were: a decrease in BUN and serum creatinine (p less than 0.001) and an increase in the creatinine clearance (Ccr) (p less than 0.001), urine volume (p less than 0.001), osmolar clearance (Cosm) (p less than 0.001), and urine creatinine (p less than 0.001) values. The IAP correlated directly with the TPR (r = +0.35, p less than 0.01) and inversely with the CI (r = -0.39, p less than 0.001) and LVSW (r = -0.37, p less than 0.001) in the 126 studies of IAP performed with the 25 patients. IAP also correlated directly with BUN (r = 0.40, p less than 0.001), serum creatinine (r = 0.28, p less than 0.01), and free water clearance (CH2O) (r = 0.3, p less than 0.001); IAP correlated negatively with Ccr (r = -0.54, p less than 0.001) and Cosm (r = -0.43, p less than 0.001). In critically ill cirrhotic patients, IAP, when measured noninvasively via a bladder catheter, is an accurate and useful method to follow manipulation of ascitic fluid pressure quantitatively in order to optimize hemodynamic and renal function.
对25例因静脉曲张破裂出血、大量腹水和外周水肿而入住重症监护病房(ICU)的肝硬化患者,通过经尿道导管测量腹腔内压力(IAP),并评估血流动力学和肾功能。对于IAP大于25 cm H₂O的患者,进行腹腔穿刺放液以使IAP降低10 cm H₂O。腹腔穿刺放液后,IAP从33.47 cm H₂O降至19.06 cm H₂O(p<0.001),导致总外周阻力(TPR)降低(p<0.01),心脏指数(CI)显著升高(p<0.001)、每搏指数(p<0.001)、左心室每搏功(LVSW)(p<0.01)和右心室每搏功(p<0.01)。腹腔穿刺放液对肾功能的治疗效果为:血尿素氮(BUN)和血清肌酐降低(p<0.001),肌酐清除率(Ccr)升高(p<0.001)、尿量(p<0.001)、渗透清除率(Cosm)(p<0.001)和尿肌酐(p<0.001)值升高。在对这25例患者进行的126项IAP研究中,IAP与TPR直接相关(r=+0.35,p<0.01),与CI(r=-0.39,p<0.001)和LVSW(r=-0.37,p<0.001)呈负相关。IAP还与BUN(r=0.40,p<0.001)、血清肌酐(r=0.28,p<0.01)和自由水清除率(CH₂O)(r=0.3,p<0.001)直接相关;IAP与Ccr(r=-0.54,p<0.001)和Cosm(r=-0.43,p<0.001)呈负相关。在重症肝硬化患者中,通过膀胱导管无创测量IAP是一种准确且有用的方法,可用于定量监测腹水压力的调控,以优化血流动力学和肾功能。